Evidence map›Paper›PMID 42089148›Full record

ArticleStroke2026

Core Blood-Brain Barrier Disruption in Patients With Large Vessel Occlusion.

Richard Leigh, Nefeli Valyraki, Nae-Yuh Wang, Manar Abomulay, Adrien Ter Schiphorst, Adrián Valls Carbó, María Hernández-Pérez, Frédérique Charbonneau, Caroline Arquizan, Anne Wacongne and 11 more

Abstract readMulticenter Study
In one paragraph

Article in Stroke, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Richard LeighDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD (R.L.).ORCID 0000-0002-8285-1815
Nefeli ValyrakiDepartment of Neurology (N.V., P.S.), Hôpital Fondation A. de Rothschild, Paris, France.
Nae-Yuh WangDepartments of Medicine, Biostatistics, and Epidemiology, Johns Hopkins University, Baltimore, MD (N.-Y.W.).ORCID 0000-0001-6513-9730
Manar AbomulayDepartment of Neurology, University Hospital of Toulouse, France (M.A., J.M.O.).ORCID 0009-0002-5578-9304
Adrien Ter SchiphorstUniversité Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Team Turc, France (N.V., A.t.S., C.A., P.S.).ORCID 0000-0002-7354-3351
Adrián Valls CarbóDepartment of Neurosciencies, Germans Trias I Pujol University Hospital, Badalona, Spain (A.V.C., M.H.-P.).
María Hernández-PérezDepartment of Neurosciencies, Germans Trias I Pujol University Hospital, Badalona, Spain (A.V.C., M.H.-P.).ORCID 0000-0001-8279-7954
Frédérique CharbonneauDepartment of Radiology (F.C.), Hôpital Fondation A. de Rothschild, Paris, France.ORCID 0000-0002-3696-0834
Caroline ArquizanUniversité Paris Cité, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Team Turc, France (N.V., A.t.S., C.A., P.S.).ORCID 0000-0001-7347-1039
Anne WacongneDepartment of Neurology, Nimes University Hospital, France (A.W.).ORCID 0000-0002-3976-3772
Denis SablotDepartment of Neurology, Perpignan Hospital, France (D.S.).ORCID 0000-0002-9038-7119
Vincent CostalatDepartment of Neuroradiology (V.C.), CHRU Gui de Chauliac, Montpellier, France.
Canan OzsancakCRFA Le COTEAU-UGECAM, La Chapelle-Saint Mesmin, France (C.O.).ORCID 0000-0002-5537-5630
Clara CohenDepartment of Neuroradiology, University Hospital Center of Orleans, France (C.C.).ORCID 0000-0002-8200-2784
Marco PasiDepartment of Neurology (M.P.), Centres d'Investigation Clinique-Innovation Technologique (CIC-IT) 1415, INSERM 1253 iBrain, Centre Hospitalier Universitaire de Tours, Université de Tours, France.ORCID 0000-0001-9976-2459
Grégoire BoulouisDepartment of Diagnostic and Interventional Neuroradiology (G.B.), Centres d'Investigation Clinique-Innovation Technologique (CIC-IT) 1415, INSERM 1253 iBrain, Centre Hospitalier Universitaire de Tours, Université de Tours, France.ORCID 0000-0001-8422-9205
Nicole YuenDepartment of Neurology, Stanford Stroke Center, CA (N.Y., G.W.A.).ORCID 0000-0003-3206-6656
Jean-Philippe DesillesInterventional Neuroradiology Department, Rothschild Foundation Hospital, Paris, France (J.-P.D.).ORCID 0000-0001-8395-6312
Gregory W AlbersDepartment of Neurology, Stanford Stroke Center, CA (N.Y., G.W.A.).ORCID 0000-0003-0263-4632
Jean Marc OlivotDepartment of Neurology, University Hospital of Toulouse, France (M.A., J.M.O.).ORCID 0000-0003-2027-2276
Pierre SenersDepartment of Neurology (N.V., P.S.), Hôpital Fondation A. de Rothschild, Paris, France.ORCID 0000-0002-2134-0691

Funding

Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive DeclineR01NS123386 · NINDS · JOHNS HOPKINS UNIVERSITY · PI RICHARD LEIGH · 2022 to 2026
$3.1M
NINDS NIH HHS R01 NS123386
6 · The paper itself

Abstract

backgroundMultimodal imaging has expanded treatment for patients with acute ischemic stroke with large vessel occlusion. Blood-brain barrier (BBB) disruption measured in the ischemic core is associated with hemorrhagic transformation. However, the associations between core BBB disruption (cBBBD) and baseline clinical/imaging variables, as well as 3-month outcome, have not been explored.

methodsThis is a retrospective multicenter analysis of consecutive anterior circulation patients with acute ischemic stroke with large vessel occlusion, presenting over a 4-year time period, who were transferred from a primary to a comprehensive stroke center for possible endovascular therapy, with magnetic resonance imaging that included perfusion-weighted imaging before transfer. Magnetic resonance imaging scans were processed using RAPID software to generate penumbral imaging variables. Perfusion-weighted images were processed to detect and quantify contrast leakage; cBBBD was calculated as the average of all leaky voxels in the ischemic core. Poor functional outcome was defined as a modified Rankin Scale score of >2 at 3 months. Linear regression was used except for the outcome, which used logistic regression, controlling for age, stroke severity, and baseline functional status.

resultsOut of 411 patients transferred for endovascular therapy, 291 were included in this analysis with a median age of 74 years; 49% were female patients. The median National Institutes of Health Stroke Scale score was 13, the mean core volume was 32.3 mL, and the mean cBBBD was 2.1%. 71% of patients underwent endovascular therapy. Admission National Institutes of Health Stroke Scale score (

conclusionsIn acute ischemic stroke with large vessel occlusion, disruption of the BBB in the core lesion is independently associated with clinical outcome. cBBBD represents a new imaging profile for acute stroke that may help guide treatments.

Indexed as

Blood-Brain BarrierBrain IschemiaIschemic StrokeStrokeAgedAged, 80 and overEndovascular ProceduresFemaleHumansMaleMiddle AgedPerfusion Magnetic Resonance ImagingRetrospective Studiesangiographyblood-brain barrierendovascular proceduresischemic strokemagnetic resonance imaging

Identifiers

PMID42089148
PMCPMC13151992

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.